Avantis CIBC International Equity ETF (TSX:CADE)
21.14
+0.57 (2.77%)
May 6, 2026, 3:30 PM EST
8.24% (1Y)
| Assets | 75.07M |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 12,281 |
| Open | 21.09 |
| Previous Close | 20.57 |
| Day's Range | 21.07 - 21.14 |
| 52-Week Low | 18.73 |
| 52-Week High | 21.20 |
| Beta | n/a |
| Holdings | 1748 |
| Inception Date | Mar 13, 2026 |
About CADE
Avantis CIBC International Equity ETF is an exchange traded fund launched and managed by CIBC Asset Management Inc. The fund is co-managed by Avantis Investors. It invests in public equity markets of global ex-Canada region. The fund invests in stocks of companies operating across diversified sectors. It invests in value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the MSCI EAFE IMI Index. Avantis CIBC International Equity ETF was formed on March 13, 2026 and is domiciled in Canada.
Asset Class Equity
Category Total Market
Stock Exchange Toronto Stock Exchange
Ticker Symbol CADE
Provider CIBC
Top 10 Holdings
11.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Cash & Cash Equivalents | n/a | 2.60% |
| ASML Holding N.V. | ASML | 1.70% |
| Roche Holding AG | ROP | 1.38% |
| Shell plc | SHEL | 1.26% |
| Novartis AG ADR | NVSN.MX | 0.95% |
| BHP Group Limited | BHP | 0.93% |
| Banco Bilbao Vizcaya Argentaria, S.A. | BBVA | 0.81% |
| HSBC Holdings PLC ADR | HBC2.DE | 0.81% |
| GSK plc | GSK | 0.77% |
| AstraZeneca PLC | AZN | 0.74% |